0017 GMT - There's no rush to pick up NIB shares even though the stock looks inexpensive, Citi analyst Nigel Pittaway says. He tells clients in a note that he expects the stock to trade at current levels for some time as the market waits for reassurance on the impact of the health insurer's change of CEO. Investors also want evidence that NIB has claims inflation under control, he adds. Citi lowers its target price 1.5% to A$6.45 and keeps a neutral rating on the stock. Shares are down 3.7% at A$5.74. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
November 12, 2024 19:17 ET (00:17 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。